These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 17235714

  • 1. Antitumor effect of gemcitabine on orthotopically inoculated human gallbladder cancer cells in nude mice.
    Mita Y, Ajiki T, Kamigaki T, Okazaki T, Hori H, Horiuchi H, Hirata K, Fujita T, Fujimori T, Kuroda Y.
    Ann Surg Oncol; 2007 Apr; 14(4):1374-80. PubMed ID: 17235714
    [Abstract] [Full Text] [Related]

  • 2. Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation.
    Iwase R, Haruki K, Fujiwara Y, Furukawa K, Shiba H, Uwagawa T, Misawa T, Ohashi T, Yanaga K.
    J Surg Res; 2013 Sep; 184(1):605-12. PubMed ID: 23830367
    [Abstract] [Full Text] [Related]

  • 3. [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms].
    Fan YZ, Chen CQ, Zhao ZM, Sun W.
    Zhonghua Yi Xue Za Zhi; 2006 Mar 14; 86(10):693-9. PubMed ID: 16681930
    [Abstract] [Full Text] [Related]

  • 4. Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice.
    Bruns CJ, Shrader M, Harbison MT, Portera C, Solorzano CC, Jauch KW, Hicklin DJ, Radinsky R, Ellis LM.
    Int J Cancer; 2002 Nov 10; 102(2):101-8. PubMed ID: 12385004
    [Abstract] [Full Text] [Related]

  • 5. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.
    Bruns CJ, Harbison MT, Davis DW, Portera CA, Tsan R, McConkey DJ, Evans DB, Abbruzzese JL, Hicklin DJ, Radinsky R.
    Clin Cancer Res; 2000 May 10; 6(5):1936-48. PubMed ID: 10815919
    [Abstract] [Full Text] [Related]

  • 6. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.
    Shi Y, Fan Y, Hu Y, Jing J, Wang C, Wu Y, Geng Q, Dong X, Li E, Dong D.
    J Cell Mol Med; 2020 Jan 10; 24(1):760-771. PubMed ID: 31762191
    [Abstract] [Full Text] [Related]

  • 7. Ribonucleotide reductase subunit M1 is a possible chemoresistance marker to gemcitabine in biliary tract carcinoma.
    Ohtaka K, Kohya N, Sato K, Kitajima Y, Ide T, Mitsuno M, Miyazaki K.
    Oncol Rep; 2008 Aug 10; 20(2):279-86. PubMed ID: 18636187
    [Abstract] [Full Text] [Related]

  • 8. A MEK inhibitor (U0126) prolongs survival in nude mice bearing human gallbladder cancer cells with K-ras mutation: analysis in a novel orthotopic inoculation model.
    Horiuchi H, Kawamata H, Fujimori T, Kuroda Y.
    Int J Oncol; 2003 Oct 10; 23(4):957-63. PubMed ID: 12963974
    [Abstract] [Full Text] [Related]

  • 9. Synergic effect of photodynamic therapy using talaporfin sodium with conventional anticancer chemotherapy for the treatment of bile duct carcinoma.
    Nonaka Y, Nanashima A, Nonaka T, Uehara M, Isomoto H, Abo T, Nagayasu T.
    J Surg Res; 2013 May 10; 181(2):234-41. PubMed ID: 22835954
    [Abstract] [Full Text] [Related]

  • 10. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT, Fan YZ, Chen CQ, Zhao ZM, Sun W.
    Int J Oncol; 2012 May 10; 40(5):1501-14. PubMed ID: 22200632
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer.
    Wang FT, Wang H, Wang QW, Pan MS, Li XP, Sun W, Fan YZ.
    Cancer Chemother Pharmacol; 2020 Aug 10; 86(2):221-232. PubMed ID: 32654071
    [Abstract] [Full Text] [Related]

  • 12. Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB.
    Zhang DC, Liu JL, Ding YB, Xia JG, Chen GY.
    Acta Pharmacol Sin; 2013 Feb 10; 34(2):301-8. PubMed ID: 23274410
    [Abstract] [Full Text] [Related]

  • 13. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
    Fan YZ, Zhao ZM, Fu JY, Chen CQ, Sun W.
    Hepatobiliary Pancreat Dis Int; 2010 Aug 10; 9(4):414-22. PubMed ID: 20688607
    [Abstract] [Full Text] [Related]

  • 14. Pretreatment with Gemcitabine/5-Fluorouracil Enhances the Cytotoxicity of Trastuzumab to HER2-Negative Human Gallbladder Cancer Cells In Vitro and In Vivo.
    Wang W, Hu Z, Huang Y, Zheng H, Sun Q, Yang Q, Zhang Y, Zhang L, Wang W.
    Biomed Res Int; 2019 Aug 10; 2019():9205851. PubMed ID: 31019975
    [Abstract] [Full Text] [Related]

  • 15. Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells.
    Yu Y, Wang J, Xia N, Li B, Jiang X.
    Oncol Rep; 2015 Apr 10; 33(4):1683-90. PubMed ID: 25633045
    [Abstract] [Full Text] [Related]

  • 16. Establishment of a novel orthotopic xenograft model of human gallbladder carcinoma.
    Egberts JH, Schniewind B, Schafmayer C, Kruse ML, Sipos B, Fändrich F, Kalthoff H, Tepel J.
    Clin Exp Metastasis; 2007 Apr 10; 24(3):141-8. PubMed ID: 17406986
    [Abstract] [Full Text] [Related]

  • 17. Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme.
    Moehler M, Maderer A, Schimanski C, Kanzler S, Denzer U, Kolligs FT, Ebert MP, Distelrath A, Geissler M, Trojan J, Schütz M, Berie L, Sauvigny C, Lammert F, Lohse A, Dollinger MM, Lindig U, Duerr EM, Lubomierski N, Zimmermann S, Wachtlin D, Kaiser AK, Schadmand-Fischer S, Galle PR, Woerns M, Working Group of Internal Oncology.
    Eur J Cancer; 2014 Dec 10; 50(18):3125-35. PubMed ID: 25446376
    [Abstract] [Full Text] [Related]

  • 18. Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma.
    von Delius S, Lersch C, Schulte-Frohlinde E, Mayr M, Schmid RM, Eckel F.
    BMC Cancer; 2005 Jun 12; 5():61. PubMed ID: 15949047
    [Abstract] [Full Text] [Related]

  • 19. Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells.
    Kitagawa K, Moriya K, Kaji K, Saikawa S, Sato S, Nishimura N, Namisaki T, Akahane T, Mitoro A, Yoshiji H.
    Int J Mol Sci; 2020 Oct 14; 21(20):. PubMed ID: 33066548
    [Abstract] [Full Text] [Related]

  • 20. Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials.
    Wagner AD, Buechner-Steudel P, Moehler M, Schmalenberg H, Behrens R, Fahlke J, Wein A, Behl S, Kuss O, Kleber G, Fleig WE.
    Br J Cancer; 2009 Dec 01; 101(11):1846-52. PubMed ID: 19904267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.